The consumption of new psychoactive substances (NPS) entails significant health risks and has led to deaths throughout Europe. In 2013, a new drug, 4,4’-DMAR, was linked to 26 deaths in Hungary and the United Kingdom. Between November 2013 and April 2014, another new synthetic drug, MT-45, was associated with 13 non-fatal intoxications and 21 deaths in Sweden.
Many NPS mimic the effect of ‘traditional’ drugs like cocaine and cannabis, but are sold at lower prices. Europol and the European Monitoring Centre for Drugs and Drugs Addiction (EMCDDA) monitor these threats and work with Member States to identify new trends and combat the distribution of NPS.
In August 2014, Europol supported Scottish authorities in the implementation of Operation Redwall, which targeted NPS through nationwide operational activities including an awareness-raising campaign.